Nautic-backed CarepathRx to buy UPMC’s Chartwell for $400m

CarepathRx, which is backed by Nautic Partners, will acquire the University of Pittsburgh Medical Center’s pharmacy operations Chartwell for $400 million.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this